Patents by Inventor Gary G. Schwartz

Gary G. Schwartz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for detecting risk of fatal prostate cancer using serum calcium
    Patent number: 9470697
    Abstract: A method of screening for increased risk of fatal prostate cancer in a subject comprises providing a blood sample collected from the subject, and then detecting the presence or absence of an increased level of serum calcium in the sample. An increased level of serum calcium indicates the subject is at increased risk of fatal prostate cancer.
    Type: Grant
    Filed: September 24, 2014
    Date of Patent: October 18, 2016
    Assignee: Wake Forest University Health Services
    Inventors: Gary G. Schwartz, Halcyon G. Skinner
  • Methods of detecting ovarian cancer
    Patent number: 9297814
    Abstract: Methods of screening human female subject for a risk of ovarian cancer are described. High levels of calcium in serum are shown to be significantly positively associated with the risk of ovarian cancer and can advantageously be used to triage women into risk categories for more intensive testing. Also included are preoperative methods of determining if an adnexal mass is likely to be malignant or benign.
    Type: Grant
    Filed: January 6, 2014
    Date of Patent: March 29, 2016
    Assignees: WISCONSIN ALUMNI RESEARCH FOUDATION, WAKE FOREST UNIVERSITY HEALTH SCIENCES
    Inventors: Halcyon Gerald Skinner, Gary G. Schwartz
  • METHODS FOR DETECTING RISK OF FATAL PROSTATE CANCER USING SERUM CALCIUM
    Publication number: 20150010934
    Abstract: A method of screening for increased risk of fatal prostate cancer in a subject comprises providing a blood sample collected from the subject, and then detecting the presence or absence of an increased level of serum calcium in the sample. An increased level of serum calcium indicates the subject is at increased risk of fatal prostate cancer.
    Type: Application
    Filed: September 24, 2014
    Publication date: January 8, 2015
    Inventors: Gary G. Schwartz, Halcyon G. Skinner
  • Methods for detecting risk of fatal prostate cancer using serum calcium
    Patent number: 8871458
    Abstract: A method of screening for increased risk of fatal prostate cancer in a subject comprises providing a blood sample collected from the subject, and then detecting the presence or absence of an increased level of serum calcium in the sample. An increased level of serum calcium indicates the subject is at increased risk of fatal prostate cancer.
    Type: Grant
    Filed: December 22, 2009
    Date of Patent: October 28, 2014
    Assignee: Wake Forest University Health Sciences
    Inventors: Gary G. Schwartz, Halcyon G. Skinner
  • METHODS OF DETECTING OVARIAN CANCER
    Publication number: 20140193919
    Abstract: Methods of screening human female subject for a risk of ovarian cancer are described. High levels of calcium in serum are shown to be significantly positively associated with the risk of ovarian cancer and can advantageously be used to triage women into risk categories for more intensive testing. Also included are preoperative methods of determining if an adnexal mass is likely to be malignant or benign.
    Type: Application
    Filed: January 6, 2014
    Publication date: July 10, 2014
    Inventors: Halcyon Gerald Skinner, Gary G. Schwartz
  • METHODS FOR DETECTING RISK OF FATAL PROSTATE CANCER USING SERUM CALCIUM
    Publication number: 20100167325
    Abstract: A method of screening for increased risk of fatal prostate cancer in a subject comprises providing a blood sample collected from the subject, and then detecting the presence or absence of an increased level of serum calcium in the sample. An increased level of serum calcium indicates the subject is at increased risk of fatal prostate cancer.
    Type: Application
    Filed: December 22, 2009
    Publication date: July 1, 2010
    Inventors: Gary G. Schwartz, Halcyon G. Skinner
  • Methods for prevention and treatment of cancer
    Publication number: 20040087559
    Abstract: Methods for inhibiting, preventing, or treating cancer cell growth are disclosed. In one embodiment, the method comprises the step of administering to a patient an effective amount of a metabolic precursor of 1,25-dihydroxyvitamin D, or an analog or a derivative thereof, to increase levels of the metabolic precursor available to a target cell. In a preferred embodiment, the metabolic precursor is 25-hydroxyvitamin D.
    Type: Application
    Filed: October 28, 2003
    Publication date: May 6, 2004
    Inventors: Gary G. Schwartz, Balakrishna L. Lokeshwar, Tai C. Chen, Lyman W. Whitlatch, Michael F. Holick
  • Cadmium is a risk factor for human pancreatic cancer
    Patent number: 6383817
    Abstract: The present invention provides a method of screening for risk of pancreatic cancer in a subject, wherein the presence or absence of increased levels of cadmium in the subject is detected and wherein the presence of increased levels of cadmium in the subject indicates that the subject is at increased risk of pancreatic cancer.
    Type: Grant
    Filed: December 22, 2000
    Date of Patent: May 7, 2002
    Assignee: Wake Forest University
    Inventor: Gary G. Schwartz
  • Cadmium is a risk factor for human pancreatic cancer
    Publication number: 20020009808
    Abstract: The present invention provides a method of screening for risk of pancreatic cancer in a subject, comprising detecting the presence or absence of increased levels of cadmium in said subject, the presence of increased levels of cadmium in said subject indicating the subject is at increased risk of pancreatic cancer.
    Type: Application
    Filed: December 22, 2000
    Publication date: January 24, 2002
    Inventor: Gary G. Schwartz